{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T17:59:53Z","timestamp":1761155993279},"reference-count":39,"publisher":"Wiley","issue":"12","license":[{"start":{"date-parts":[[2015,8,30]],"date-time":"2015-08-30T00:00:00Z","timestamp":1440892800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"name":"Sanquin Blood Supply Foundation, a not-for-profit organization"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Transfusion"],"published-print":{"date-parts":[[2015,12]]},"abstract":"<jats:sec><jats:title>BACKGROUND<\/jats:title><jats:p>The availability of costly safety measures against transfusion\u2010transmissible infections forces Western countries to confront difficult ethical questions. How to decide about implementing such measures? When are such decisions justified? As a preliminary to addressing these questions, we assessed which concerns shape actual donor blood safety policymaking in five Western countries.<\/jats:p><\/jats:sec><jats:sec><jats:title>STUDY DESIGN AND METHODS<\/jats:title><jats:p>Our qualitative study involved determining which issues had been discussed in advisory committee meetings and capturing these issues in general categories. Appropriate documents were identified in collaboration with local decision\u2010making experts in Canada, Germany, the Netherlands, the United States, and the United Kingdom. The introduction of hepatitis B virus nucleic acid testing and selected measures against variant Creutzfeldt\u2010Jakob disease, West Nile virus, and Q\u2010fever were chosen as cases representing decision\u2010making on safety measures with high costs and low or uncertain added safety.<\/jats:p><\/jats:sec><jats:sec><jats:title>RESULTS<\/jats:title><jats:p>A broad inventory of concerns was established, including: 1) nine categories of advantages and disadvantages of candidate safety policies; 2) six kinds of difficulties in assessing risks and forecasting the effects of safety policies; 3) 13 decision\u2010making principles; and 4) six kinds of practical barriers hampering the translation of candidate policies into decisions.<\/jats:p><\/jats:sec><jats:sec><jats:title>CONCLUSION<\/jats:title><jats:p>Blood safety policymaking involves a wide variety of competing concerns, and approaches to reconcile these considerations are themselves contested. Developing a systematic decision\u2010making approach requires ethical reflection on, among others, reasonable costs of safety and the value of transparency in public policy.<\/jats:p><\/jats:sec>","DOI":"10.1111\/trf.13254","type":"journal-article","created":{"date-parts":[[2015,9,2]],"date-time":"2015-09-02T15:04:41Z","timestamp":1441206281000},"page":"2816-2825","source":"Crossref","is-referenced-by-count":12,"title":["An inventory of concerns behind blood safety policies in five Western countries"],"prefix":"10.1111","volume":"55","author":[{"given":"Koen","family":"Kramer","sequence":"first","affiliation":[{"name":"Department of Blood-borne Infections Sanquin Blood Supply Foundation Amsterdam"},{"name":"the Department of Communication, Philosophy, and Technology Wageningen University and Research Center Wageningen the Netherlands."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcel F.","family":"Verweij","sequence":"additional","affiliation":[{"name":"the Department of Communication, Philosophy, and Technology Wageningen University and Research Center Wageningen the Netherlands."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hans L.","family":"Zaaijer","sequence":"additional","affiliation":[{"name":"Department of Blood-borne Infections Sanquin Blood Supply Foundation Amsterdam"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2015,8,30]]},"reference":[{"key":"e_1_2_8_2_1","volume-title":"The royal commission of inquiry on the blood system in Canada. Final report: Commission of inquiry on the blood system in Canada","author":"Krever H.","year":"1997"},{"key":"e_1_2_8_3_1","volume-title":"HIV and the blood supply: an analysis of crisis decisionmaking","author":"Leveton LB","year":"1995"},{"key":"e_1_2_8_4_1","first-page":"1","volume-title":"Blood feuds: AIDS, blood, and the politics of medical disaster","author":"Bayer R","year":"1999"},{"key":"e_1_2_8_5_1","volume-title":"Blood: an epic history of medicine and commerce","author":"Starr DP.","year":"2002"},{"key":"e_1_2_8_6_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-136-4-200202190-00011"},{"key":"e_1_2_8_7_1","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1093\/oso\/9780195129298.003.0007","volume-title":"Blood feuds: AIDS, blood, and the politics of medical disaster","author":"Dressler S.","year":"1999"},{"key":"e_1_2_8_8_1","doi-asserted-by":"publisher","DOI":"10.1111\/trf.12373"},{"key":"e_1_2_8_9_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.seminhematol.2006.02.003"},{"key":"e_1_2_8_10_1","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1093\/oso\/9780195129298.003.0012","volume-title":"Blood feuds: AIDS, blood, and the politics of medical disaster","author":"Glied S.","year":"1999"},{"key":"e_1_2_8_11_1","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1093\/oso\/9780195129298.003.0013","volume-title":"Blood feuds: AIDS, blood, and the politics of medical disaster","author":"Marmor TR","year":"1999"},{"key":"e_1_2_8_12_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-07-077370"},{"key":"e_1_2_8_13_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.seminhematol.2006.02.001"},{"key":"e_1_2_8_14_1","first-page":"193","volume-title":"Policy alternatives in transfusion medicine","author":"AuBuchon JP","year":"2001"},{"key":"e_1_2_8_15_1","doi-asserted-by":"publisher","DOI":"10.1017\/CBO9780511545245.030"},{"key":"e_1_2_8_16_1","volume-title":"Brief van de Minister van Volksgezondheid, Welzijn en Sport [Internet]","author":"Schippers EI.","year":"2012"},{"key":"e_1_2_8_17_1","volume-title":"Ministerieel plan bloedvoorziening 2015\u20102017 [Internet]","author":"Schippers EI.","year":"2014"},{"key":"e_1_2_8_18_1","volume-title":"Zicht op zinnige en duurzame zorg [Internet]","year":"2006"},{"key":"e_1_2_8_19_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMp0806862"},{"key":"e_1_2_8_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2010.02.021"},{"key":"e_1_2_8_21_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1423-0410.2002.00198.x"},{"key":"e_1_2_8_22_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1537-2995.2011.03319.x"},{"key":"e_1_2_8_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tmrv.2011.01.004"},{"key":"e_1_2_8_24_1","first-page":"1","volume-title":"Can policy decisions in transfusion medicine be evidence based? Decision making in transfusion medicine","author":"Vamvakas EC.","year":"2011"},{"key":"e_1_2_8_25_1","volume-title":"Risk\u2010based decision\u2010making framework for blood safety [Internet]","year":"2015"},{"key":"e_1_2_8_26_1","doi-asserted-by":"publisher","DOI":"10.1111\/trf.12569"},{"key":"e_1_2_8_27_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1423-0410.2011.01526.x"},{"key":"e_1_2_8_28_1","doi-asserted-by":"publisher","DOI":"10.1111\/trf.13080"},{"key":"e_1_2_8_29_1","first-page":"19","volume-title":"Policy alternatives in transfusion medicine","author":"Sugerman J","year":"2001"},{"key":"e_1_2_8_30_1","first-page":"71","volume-title":"Ethical issues in transfusion medicine","author":"Bredehoeft SJ.","year":"2001"},{"key":"e_1_2_8_31_1","first-page":"137","volume-title":"Ethical issues in transfusion medicine","author":"Chamber LA.","year":"2001"},{"key":"e_1_2_8_32_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.2003.00392.x"},{"key":"e_1_2_8_33_1","volume-title":"Grounded Theory Online. What is grounded theory? [Internet]","year":"2015"},{"key":"e_1_2_8_34_1","volume-title":"Principles of biomedical ethics","author":"Beauchamp TL","year":"2001"},{"key":"e_1_2_8_35_1","doi-asserted-by":"publisher","DOI":"10.1023\/B:MHEP.0000021848.75590.b0"},{"key":"e_1_2_8_36_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1467-8519.2009.01709.x"},{"key":"e_1_2_8_37_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1088-4963.1997.tb00082.x"},{"key":"e_1_2_8_38_1","doi-asserted-by":"publisher","DOI":"10.1377\/hlthaff.17.5.50"},{"key":"e_1_2_8_39_1","first-page":"160","article-title":"Political action: the problem of dirty hands","volume":"2","author":"Walzer M.","year":"1973","journal-title":"Philos Public Aff"},{"key":"e_1_2_8_40_1","doi-asserted-by":"publisher","DOI":"10.1017\/S0007123400003033"}],"container-title":["Transfusion"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Ftrf.13254","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Ftrf.13254","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/trf.13254","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,10]],"date-time":"2024-06-10T21:50:35Z","timestamp":1718056235000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/trf.13254"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8,30]]},"references-count":39,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["10.1111\/trf.13254"],"URL":"https:\/\/doi.org\/10.1111\/trf.13254","archive":["Portico"],"relation":{},"ISSN":["0041-1132","1537-2995"],"issn-type":[{"value":"0041-1132","type":"print"},{"value":"1537-2995","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,8,30]]}}}